Hidoc Dr | Medical Learning App for Doctors

Today's Updates

Verekitug's Quarterly Dosing Cuts Asthma Burden, With Michael Wechsler, MD Michael Wechsler, MD, MSc

Published Date: 19 Oct 2026

Wechsler discusses why less frequent dosing matters to patients with severe asthma, plus VALIANT's safety profile and what's next for the field.

Tozorakimab Cuts COPD Mucus Plugging, With George Washko, MD

Published Date: 19 Oct 2026

Tozorakimab Cuts COPD Mucus Plugging, With George Washko, MD

Chronic Proton Pump Inhibitor Use Linked to More Asthma Exacerbations

Published Date: 19 Oct 2026

Chronic Proton Pump Inhibitor Use Linked to More Asthma Exacerbations

FDA Approves Autoinjector for Self-Administered Zilucoplan in Generalized Myasthenia Gravis Marco Meglio

Published Date: 19 Oct 2026

Adults with generalized myasthenia gravis who are anti-acetylcholine receptor antibody positive now have a second self-administration option for the complement inhibitor zilucoplan.

Levacetylleucine Shows Sustained Benefit at 3 Years in Niemann-Pick Disease Marco Meglio

Published Date: 19 Oct 2026

Three-year extension data from the phase 3 IB1001-301 trial show levacetylleucine slowed disease progression in both adults and children with Niemann-Pick disease type C.

Recognizing Familial Chylomicronemia Syndrome in the APOC3 Era

Published Date: 19 Oct 2026

Recognizing Familial Chylomicronemia Syndrome in the APOC3 Era

Knowledge Hub

Oncology

Smart Oncology Infusion Chairs With Integrated Treatment Data: Transforming Chemotherapy Delivery and Patient Monitoring

Review of smart oncology infusion chairs with integrated data systems improving cancer care delivery.

Oncology

Intracellular Nanobody Therapeutics: Mechanisms, Clinical Relevance, and Emerging Applications

Review of intracellular nanobody therapeutics for targeting undruggable intracellular disease drivers.

Oncology

Screening for Occult Leptomeningeal Disease Through Cerebrospinal Fluid Tumor DNA Analysis

Review of CSF tumor DNA analysis for early detection of occult leptomeningeal disease in oncology.

Oncology

Preventing Immune Effector Cell-Associated Neurotoxicity Through Early Neurovascular Biomarker Surveillance

Review of early neurovascular biomarker surveillance in preventing immune effector cell-associated neurotoxicity for clinicians.

Oncology

KOL Videos

Hidoc Dr| Hidoc- US| Hidoc - Doctor Netwoking Platform| Educational resource for HCPs

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug Database Drug Interaction Diseases Database

KOL Videos Knowledge Hub Quizzes

Medical Updates Events About Us

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation

Your one-stop Solution for MEDICAL LEARNING & UPDATES

Verekitug's Quarterly Dosing Cuts Asthma Burden, With Michael Wechsler, MD Michael Wechsler, MD, MSc

Tozorakimab Cuts COPD Mucus Plugging, With George Washko, MD

Chronic Proton Pump Inhibitor Use Linked to More Asthma Exacerbations

FDA Approves Autoinjector for Self-Administered Zilucoplan in Generalized Myasthenia Gravis Marco Meglio

Levacetylleucine Shows Sustained Benefit at 3 Years in Niemann-Pick Disease Marco Meglio

Recognizing Familial Chylomicronemia Syndrome in the APOC3 Era

Knowledge Hub

Smart Oncology Infusion Chairs With Integrated Treatment Data: Transforming Chemotherapy Delivery and Patient Monitoring

Intracellular Nanobody Therapeutics: Mechanisms, Clinical Relevance, and Emerging Applications

Screening for Occult Leptomeningeal Disease Through Cerebrospinal Fluid Tumor DNA Analysis

Preventing Immune Effector Cell-Associated Neurotoxicity Through Early Neurovascular Biomarker Surveillance

Screening for Treatment-Related Sarcopenia in Cancer Care

Tissue Reconstruction After Extensive Cancer Surgery: Advances, Challenges, and Clinical Considerations

Therapeutic RNA Vaccines for Melanoma

KOL Videos

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part IV

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part III

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II

An In-Depth Look At The Signs And Symptoms Of Lymphoma- Further Discussion

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VIII

Current Scenario of Cancer- Q&A Session to Close the Gap Part II

Quick Links

Page Views

Your one-stop Solution for MEDICAL LEARNING & UPDATES

Verekitug's Quarterly Dosing Cuts Asthma Burden, With Michael Wechsler, MD Michael Wechsler, MD, MSc

Tozorakimab Cuts COPD Mucus Plugging, With George Washko, MD

Chronic Proton Pump Inhibitor Use Linked to More Asthma Exacerbations

FDA Approves Autoinjector for Self-Administered Zilucoplan in Generalized Myasthenia Gravis Marco Meglio

Levacetylleucine Shows Sustained Benefit at 3 Years in Niemann-Pick Disease Marco Meglio

Recognizing Familial Chylomicronemia Syndrome in the APOC3 Era

Knowledge Hub

Smart Oncology Infusion Chairs With Integrated Treatment Data: Transforming Chemotherapy Delivery and Patient Monitoring

Intracellular Nanobody Therapeutics: Mechanisms, Clinical Relevance, and Emerging Applications

Screening for Occult Leptomeningeal Disease Through Cerebrospinal Fluid Tumor DNA Analysis

Preventing Immune Effector Cell-Associated Neurotoxicity Through Early Neurovascular Biomarker Surveillance

Screening for Treatment-Related Sarcopenia in Cancer Care

Tissue Reconstruction After Extensive Cancer Surgery: Advances, Challenges, and Clinical Considerations

Therapeutic RNA Vaccines for Melanoma

KOL Videos

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part IV

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part III

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II

An In-Depth Look At The Signs And Symptoms Of Lymphoma- Further Discussion

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VIII

Current Scenario of Cancer- Q&A Session to Close the Gap Part II

Quick Links

Verification

Welcome to Hidoc Dr.

Page Views